ArticleTrials2020

The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan.

Mark A Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.